- Home
- PHAR vs ORC Comparison
PHAR vs ORC Comparison
Compare PHAR & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- ORC
- Stock Information
- Founded
- PHAR 1988
- ORC 2010
- Country
- PHAR Netherlands
- ORC United States
- Employees
- PHAR N/A
- ORC N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- PHAR Health Care
- ORC Real Estate
- Exchange
- PHAR Nasdaq
- ORC Nasdaq
- Market Cap
- PHAR 618.3M
- ORC 623.6M
- IPO Year
- PHAR N/A
- ORC 2013
- Fundamental
- Price
- PHAR $8.42
- ORC $8.26
- Analyst Decision
- PHAR Strong Buy
- ORC Buy
- Analyst Count
- PHAR 3
- ORC 3
- Target Price
- PHAR $27.00
- ORC $9.50
- AVG Volume (30 Days)
- PHAR 5.6K
- ORC 3.0M
- Earning Date
- PHAR 03-13-2025
- ORC 01-30-2025
- Dividend Yield
- PHAR N/A
- ORC 17.43%
- EPS Growth
- PHAR N/A
- ORC N/A
- EPS
- PHAR N/A
- ORC 0.58
- Revenue
- PHAR $285,745,000.00
- ORC $54,406,000.00
- Revenue This Year
- PHAR $20.08
- ORC N/A
- Revenue Next Year
- PHAR $9.22
- ORC N/A
- P/E Ratio
- PHAR N/A
- ORC $14.41
- Revenue Growth
- PHAR 30.64
- ORC N/A
- 52 Week Low
- PHAR $6.65
- ORC $7.41
- 52 Week High
- PHAR $13.20
- ORC $9.08
- Technical
- Relative Strength Index (RSI)
- PHAR 40.05
- ORC 62.14
- Support Level
- PHAR $7.95
- ORC $7.88
- Resistance Level
- PHAR $9.35
- ORC $8.38
- Average True Range (ATR)
- PHAR 0.52
- ORC 0.18
- MACD
- PHAR -0.16
- ORC 0.04
- Stochastic Oscillator
- PHAR 22.76
- ORC 81.51
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.